Useful Links & Tools
- MSDS
- Specification Sheet
- Certificate of Analysis
- Certificate of Origin
- Bulk Quote
- Similar Products
443549
Sigma-Aldrich
Diethyl ether
anhydrous, ACS reagent, ≥99.0%, contains 1 ppm BHT as inhibitor
| Synonym: | Ether, Ethyl ether |
| CAS Number: | 60-29-7 |
| Linear Formula: | (CH3CH2)2O |
| Molecular Weight: | 74.12 |
| Beilstein Registry Number: | 1696894 |
| EC Number: | 200-467-2 |
| MDL number: | MFCD00011646 |
| PubChem Substance ID: | 24868063 |
Description
| Frequently Asked Questions | Live Chat and Frequently Asked Questions |
| Packaging | 1, 12×1 L in alum btl |
| 10 L in ss drum | |
| 20 L in steel drum | |
| 4, 4×4 L in safety can |
Properties
| grade | ACS reagent |
| anhydrous | |
| vapor density | 2.6 (vs air) |
| vapor pressure | 28.69 psi ( 55 °C) |
| 8.59 psi ( 20 °C) | |
| assay | ≥99.0% |
| autoignition temp. | 320 °F |
| contains | 1 ppm BHT as inhibitor |
| expl. lim. | 36.5 % |
| total impurities | Alcohol ( as CH3CH2OH ), passes test |
| ≤0.0002 meq/g Titr. acid | |
| ≤0.001% Carbonyl ( as HCHO ) | |
| ≤0.03% water | |
| ≤1 ppm Peroxide ( as H2O2 ) | |
| evapn. residue | ≤0.001% |
| color | ≤10(APHA) |
| refractive index | n |
| bp | 34.6 °C(lit.) |
| mp | −116 °C(lit.) |
| density | 0.706 g/mL at 25 °C(lit.) |
Safety
| Personal Protective Equipment | Eyeshields, Faceshields, full-face respirator (US), Gloves, multi-purpose combination respirator cartridge (US) |
| Hazard Codes | F+,Xn |
| Risk Statements | 12-19-22-66-67 |
| Safety Statements | 9-16-29-33 |
| RIDADR | UN1155 3/PG 1 |
| WGK Germany | 1 |
| RTECS | KI5775000 |
| UEL | 48.00%(V) |
| LEL | 1.80%(V) |
| Flash Point(F) | -40 °F |
| Flash Point(C) | -40 °C |
References
| Merck | Merck 13,3840 |
| Beilstein | Beil. 1,IV,1314 |
| reference | Aldrich MSDS 1, 864:B / Corp MSDS 1 (1), 1549:A / FT-IR 2 (1), 302:B / FT-IR 1 (1), 203:A / FT-NMR 1 (1), 317:A / IR-Spectra (3), 124:A / IR-Spectra (2), 114:A / NMR-Reference 2 (1), 173:A / RegBook 1 (1), 209:B / Sax 6, 1350 / Structure Index 1, 29:B:1 / Vapor Phase 3, 265:B |






